Lion Point Capital »

Innate Pharma shares owned by Lion Point Capital

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $142k 81k 1.75